Retroviral integrases are essential for viral replication and represent an attractive chemotherapeutic target. In the current study, we demonstrated the activity of micromolar concentrations of dinucleotides against human immunodeficiency virus type 1 (HIV-1), HIV type 2 (HIV-2), simian immunodeficiency virus, and feline immunodeficiency virus integrases. The structure-activity relationship indicates that 5Ј-phosphorylation enhances potency and that phosphodiester and sugar modifications affect the inhibition of HIV-1 integrase. Base sequence selectivity was observed: pAC, pAT, and pCT were the most potent inhibitors, whereas pAA, pGA, and pGC showed low activity at 100 M. The inhibition by pAC is consistent with the interaction of the enzyme with the 5Ј end of the noncleaved strand (5Ј-AC-3Ј). The linear and cyclic dinucleotides released by the 3Ј-processing reaction did not affect enzymatic activity at physiological concentrations. An increase in the length to trinucleotides or tetranucleotides enhanced potency by only 2-3-fold, suggesting that two neighboring bases may be sufficient for significant interactions. Inhibition of a truncated (50 -212) integrase mutant and global inhibition of all nucleophiles in the 3Ј-processing reaction suggest that dinucleotides bind in the catalytic core. All of the active dinucleotides inhibited enzyme/DNA binding in their respective IC 50 range. Although the dinucleotides tested showed no antiviral activity, these observations demonstrate the usefulness of dinucleotides in elucidating enzyme mechanisms and as potential ligands for cocrystallization and as lead structures for development of antivirals.
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Several key enzymes in the replication cycle of the HIV can be targeted for chemotherapeutic intervention, most notably, reverse transcriptase and protease (1) . Research is now in progress to develop clinically active agents against other proteins in the viral life cycle. Toward this goal, several laboratories have investigated the pharmacological activity of various drugs as inhibitors of HIV integrase (2) (3) (4) .
Retroviruses encode the integrase protein at the 3Ј end of the pol gene (5) . This enzyme, a proteolytic cleavage product of a gag-pol fusion protein precursor, is contained in the virus particle and is required for viral replication. It integrates a double-stranded DNA copy of the RNA genome, synthesized by reverse transcriptase, into a host chromosome. During viral infection, integrase catalyzes the excision of the last two nucleotides from each 3Ј end of the linear viral DNA, leaving the terminal dinucleotide CA-3Ј-OH at these recessed 3Ј ends. This activity is referred to as the 3Ј-processing or dinucleotide cleavage. After transport to the nucleus within the preintegration complex, integrase catalyzes a DNA strand transfer reaction involving the nucleophilic attack of these ends on the host chromosome [for recent reviews, see Katz and Skalka (6) and Rice et al. (7) ].
We previously demonstrated that AZT nucleotides inhibit HIV-1 integrase with an IC 50 value of ϳ100 M (8) and recently showed that the gyrB inhibitor, coumermycin A1, and several mononucleotide analogs that are currently undergoing clinical trials as inhibitors of HIV-1 replication are more potent inhibitors of HIV-1 integrase than are AZT nucleotides (2) .
Non-nucleotide inhibitors of HIV-1 integrase have also been described (9 -12) that have the potential, as shown by molecular modeling, to stack their aromatic rings and poten-tially mimic a dinucleotide (11, 12) . Because of the structural similarities between RNase H (from either Escherichia coli or HIV-1) and retroviral integrase (from either HIV-1 or ASV) with respect to both the overall topology of the active sites and location of conserved acidic amino acids (7) and because of the recent finding that dinucleotides can inhibit RNase H (13), we theorized that dinucleotides may inhibit integrase. In the present study, we investigated the effect of dinucleotides (including those released physiologically during 3Ј-processing) on enzyme activity and the inhibition of HIV-1 integrase by a wide variety of dinucleotides having differing base sequences or modifications to the backbone or sugar moiety. These data can be used to explore the enzyme mechanisms, develop strategies for the design of integrase-inhibitor cocrystals, and develop novel integrase inhibitors.
Materials and Methods
Dinucleotides and analogs. All dinucleotides and trinucleotides were purchased from Midland Certified Reagent (Midland, TX) with the exception of the following. The 2Ј,5Ј-oligoadenylates were a gift from Dr. Robert J. Suhadolnik (Temple University, Philadelphia, PA). Nonphosphorylated dinucleotides incorporating modified nucleoside analogs were obtained from Dr. Jean-Pierre Sommadossi (University of Alabama-Birmingham, Birmingham, Alabama). The PNA dinucleotide was supplied by Dr. Peter Nielsen (University of Copenhagen, Copenhagen, Denmark). The cyclic dinucleotides were from the laboratories of Dr. Roger Jones and Dr. H. Keith Chenault.
The methylphosphonate dCpdA and phosphorothioates dCpdA and dCpdT were synthesized by phosphoramidite coupling, separated into their protected Rp and Sp diastereomers by normal-phase HPLC, chemically phosphorylated, deprotected, and purified by reverse-phase HPLC to homogeneous peaks. Each diastereomer displayed the expected mass spectra and 31 P NMR peaks. Preparation of radiolabeled DNA substrates. The following oligodeoxynucleotides were HPLC purified by and purchased from Midland Certified Reagent : AE117, 5Ј-ACTGCTAGAGATTTTCCA-CAC-3Ј; AE118, 5Ј-GTGTGGAAAATCTCTAGCAGT-3Ј; AE157, 5Ј-GAAAGCGACCGCGCC-3Ј; AE146, 5Ј-GGACGCCATAGCCCCG-GCGCGGTCGCTTTC-3Ј; AE156, 5Ј-GTGTGGAAAATCTCTA-GCAGGGGCTATGGCGTCC-3Ј; AE118S, 5Ј-GTGTGGAAAAT-CTCTAGCA-3Ј; and RM22M, 5Ј-TACTGCTAGAGATTTTCCACAC-3Ј. AE117, AE118, and the first 19 nucleotides of AE156 correspond  to the U5 end of the HIV-1 LTR. To analyze the extents of 3Ј-processing and strand transfer using 5Ј end-labeled substrates, AE118 was 5Ј end labeled using T 4 polynucleotide kinase (GIBCO BRL, Baltimore, MD) and [␥-32 P]ATP (DuPont-New England Nuclear). The kinase was heat inactivated, and AE117 was added to the same final concentration. The mixture was heated at 95°, allowed to cool slowly to room temperature, and run on a G-25 Sephadex quick-spin column (Boehringer-Mannheim Biochemicals, Indianapolis, IN) to separate annealed doublestranded oligonucleotide (Fig. 1C) from unincorporated label.
To analyze the choice of nucleophile for the 3Ј-processing reaction (14, 15) , AE118 was 3Ј end-labeled using [␣-32 P]cordycepin triphosphate (DuPont-New England Nuclear) and terminal transferase (Boehringer-Mannheim Biochemicals). The transferase was heat inactivated, and RM22M was added to the same final concentration. The mixture was heated at 95°, allowed to cool slowly to room temperature, and run on a G-25 spin column as before. To analyze the extent of strand transfer using the "precleaved" substrate, AE118S was 5Ј end-labeled, annealed to AE117, and column purified as described above. To determine the extent of 30-mer target strand generation during disintegration (the reverse of the strand transfer reaction) (16), AE157 was 5Ј end labeled; annealed to AE156, AE146, and AE117; annealed; and column purified as described above. Disintegration reactions (16) were performed as above except that the Y oligonucleotide (i.e., the branched substrate in which the U5 end was "integrated" into target DNA) was used.
Electrophoresis and quantification. Reactions were quenched by the addition of an equal volume (16 l) of Maxam-Gilbert loading dye (98% deionized formamide, 10 mM EDTA, 0.025% xylene cyanol, 0.025% bromphenol blue). An aliquot (5 l) was electrophoresed on a denaturing 20% polyacrylamide gel (0.09 M Tris-borate, pH 8.3, 2 mM EDTA, 20% acrylamide, 8 M urea). Gels were dried, exposed in a Molecular Dynamics PhosphorImager cassette (Sunnyvale, CA), and analyzed using a Molecular Dynamics PhosphorImager. Percent inhibition was calculated using the equation 100
, where C, N, and D are the fractions of 21-mer substrate converted to 19-mer (3Ј-processing product) or strand transfer products for DNA alone, DNA plus integrase, and integrase plus drug, respectively. The IC 50 value was determined by plotting the drug concentration versus percent inhibition and determining the concentration that produced 50% inhibition.
UV cross-linking experiments. We used the method of Yoshinaga et al. (19) . Briefly, integrase was incubated with substrate in reaction buffer as described above for 5 min at 30°. Reactions were then irradiated with an UV transilluminator (254-nm wavelength) from 3 cm above (2.4 mW/cm 2 ) at room temperature for 10 min. An equal volume (16 l) of 2ϫ sodium dodecyl sulfate-polyacrylamide gel electrophoresis buffer (100 mM Tris, pH 6.8, 4% 2-mercaptoethanol, 4% sodium dodecyl sulfate, 0.2% bromphenol blue, 20% glycerol) was added to each reaction, and the reaction was heated at 95°for 3 min before loading of a 20-l aliquot onto a 12% sodium dodecyl sulfate-polyacrylamide gel. The gel was run at 120 V for 1.5 hr, dried, and exposed in a PhosphorImager cassette. For inhibition of DNA binding experiments, integrase (200 nM) was preincubated with the dinucleotide (at the indicated concentration) for 30 min at 30°before the subsequent addition of the radiolabeled viral DNA substrate (20 nM) .
HIV cytopathic effect assay. HIV cytopathic effect assays were performed essentially as previously described (20) . ATH8 cells were used as the host cell line and were grown in cell culture in the absence or presence of 300 median tissue culture infective dose of HIV-1 LAI strain and in the absence or presence of dinucleotides.
Results

Inhibition of HIV-1 integrase by dinucleotides and
trinucleotides. The first dinucleotide tested was 5Ј-CA as an inhibitor of HIV-1 integrase because this sequence is conserved at the 3Ј end of all retroviral LTR sequences and immediately 5Ј from the dinucleotide cleavage site (Fig. 1A ) (5) and is critical for optimum enzymatic activity (21, 22) . To be as concise as possible, from this point on, the nonphosphorylated CA dinucleotide will be represented as CA and its 5Ј-phosphorylated version will be represented as pCA. Fig.  1A shows the oligonucleotide used in the 3Ј-processing and strand transfer reactions (Fig. 1B) . Fig. 1 , C and D, shows that CA was only minimally active against strand transfer (IC 50 ϳ 60 M) and even less active against 3Ј-processing (Ͻ50% inhibition at 132 M). Similar results were obtained for a CT dinucleotide (data not shown). Our previous observation that modification of the deoxyribose of a physiological deoxynucleotide can confer inhibitory activity against integrase (2) led us to test whether incorporation of modified nucleoside analogs (e.g., 3Ј-azido-3Ј-deoxythymidine or 2Ј,3Ј-dideoxyinosine) into a dinucleotide would result in increased potency. No increase in potency was observed (data not shown).
Our previous observation that 5Ј-phosphorylation of nucleoside analogs conferred activity against integrase (2, 8) led us to test the phosphorylated version of CA and other dinucleotides. 5Ј-Phosphorylation of CA (generating pCA) enhanced the inhibitory activity (Fig. 1, C and D) . This pCA dinucleotide also inhibited strand transfer using a precleaved oligonucleotide (which mimics the product of the 3Ј-processing reaction) consisting of sequences from the U3 end of the LTR in the same concentration range (data not shown). Interestingly, when the nonphosphorylated CA dinucleotide in which a ribose was substituted for the deoxyribose was tested, significant inhibition of both strand transfer and 3Ј-processing was observed at 100 M (Fig. 1, C and D) . Therefore, substitution of the deoxyribose by a ribose also enhanced the potency of the nonphosphorylated CA dinucleotide.
We then tested all 16 possible sequence combinations of 5Ј-phosphorylated deoxydinucleotides against HIV-1 integrase to determine whether base sequence selectivity existed ( Table 1 ). The inhibitory activity observed with pAC, pAT, and pCT is in contrast with the low level of activity observed with the pTN family (N ϭ A, C, T, or G).
The correlation between potency and oligonucleotide length was tested further using several trinucleotides and tetranucleotides. In addition, the effect of 5Ј-phosphorylation on trinucleotide potency was examined ( Table 2 ). The nonphosphorylated trinucleotides CAG and CTA inhibited 3Ј-processing at ϳ60 M (Table 2) , whereas nonphosphorylated dinucleotides were inactive in this range (Fig. 1) . The phosphorylated CTA trinucleotide showed a further enhancement of potency by ϳ2-3-fold (Table 2) , which is consistent with results obtained from dinucleotides. Two 5Ј-phosphorylated tetranucleotides corresponding to the HIV LTR end were also tested (Table 2) , and they were found to not be better inhibitors than the corresponding trinucleotides or dinucleotides (Tables 1 and 2) .
Changes in the DNA backbone. Substitution of the phosphodiester backbone of pCA by an anionic phosphorothiodiester did not abolish potency (Fig. 2) . For example, both the Rp (lanes [8] [9] [10] [11] [12] and Sp (lanes 13-17) diastereomers of pCA inhibited strand transfer, although at higher concentrations than did pCA (lanes 3-7) . The importance of the ionic character of the dinucleotide backbone in conferring potency was examined by its replacement with neutral, hydrophobic internucleotidic linkages. We examined replacement of the phosphodiester backbone in the pCA dinucleotide with a methylphosphonodiester linkage to preserve the basic phosphorus-linked backbone. Both the Rp and Sp diastereomers of the methylphosphonodiester pCA were inactive for both 3Ј-processing and strand transfer at 500 M (Fig. 2, lanes 19-24) , suggesting that the ionic character of the backbone is important. More radical alterations were tested by using a CA dinucleotide analogue with a PNA backbone (23) in the CA dinucleotide. Like the phosphodiester version, the CA with the PNA backbone exhibited IC 50 values for both 3Ј-processing and strand transfer at ϳ100 M (Fig. 2, lanes 25-29) . We conclude that the anionic character of the backbone, although important for activity (Fig. 2, compare lanes 3-7 with lanes 19-24) , can be substituted by an amide backbone, which may exhibit a partial dipole character, simulating the anionic character of the phosphodiester.
The results of sugar and backbone substitution on the CA dinucleotide are summarized in Fig. 3 . Modification of both the sugar and the internucleotidic linkage had a significant impact on potency. Taken together with the data in Table 1 , interactions between HIV-1 integrase and the base, sugar, and phosphodiester linkages all appear to play critical roles in potency (and, presumably, binding affinity).
Other backbone modifications that retained the anionic character of the backbone but altered its conformation were also tested. For example, nine available cyclic dinucleotides were assayed. Such cyclic dinucleotides can be generated by HIV-1 integrase during the 3Ј-processing reaction in vitro by the attack of the 3Ј-hydroxyl of the viral DNA on the scissile bond (14, 15) . Cyclic dinucleotides also exhibited a sequencedependent activity, although they were active at Ͼ100 M (Fig. 4) . For example, the cyclic CC dinucleotide (lanes [25] [26] [27] was the most potent of the nine tested, whereas the cyclic CT dinucleotide was inactive at 1 mM (lanes 6-8) . Interestingly, a cyclic dinucleotide with abasic sites in place of the bases (DD) also exhibited inhibitory activity (lanes 13-15) . These results are in contrast to the significant inhibition of both 3Ј-processing and strand transfer obtained with the linear, 5Ј-phosphorylated dinucleotides (Table 2) . We conclude that the cyclic structure reduces potency relative to the linear structure. In addition, 2Ј-5Ј-oligoadenylates, recently shown to be active against HIV-1 replication due to inhibition of reverse transcriptase (24) , were found to be inactive at 300 M (data not shown). These results are not unexpected given the lack of inhibition of integrase observed with the pAA (Table 1) . Therefore, the 2Ј-5Ј phosphodiester backbone does not seem to enhance potency relative to the 3Ј-5Ј linkage.
Site and mechanism of action. The binding site of these deoxyribodinucleotides was first examined by testing the dinucleotide pCT with an integrase deletion mutant containing only amino acids 50-212 (catalytic core of integrase). Because deletion mutants of integrase are inactive in both 3Ј-processing and strand transfer (17) but can catalyze the disintegration reaction (16) , the branched Y oligonucleotide was used as the substrate. Our finding that the integrase deletion mutant missing both the amino-terminal zinc finger and the carboxyl-terminal DNA-binding domains could be inhibited by pCT (Fig. 5A) suggests that dinucleotides bind in the catalytic core.
The second question we asked was whether dinucleotides affected the choice of nucleophile in the 3Ј-processing reaction. An oligonucleotide substrate labeled at the 3Ј end was used for these experiments (14, 15) . As seen in Fig. 5B , all of the dinucleotides tested inhibited glycerolysis, hydrolysis, and circular nucleotide formation to the same extent. Thus, dinucleotides exert a global inhibition by blocking the use of the three nucleophiles (glycerol, water, or the hydroxyl group of the viral DNA terminus) in the 3Ј-processing reaction. These results are consistent with the binding of dinucleotides to the central core domain of the HIV-1 integrase.
We next wanted to determine whether dinucleotides inhibited binding of the substrate DNA, which presumably interacts with the catalytic acidic acid residues Asp64, Asp116, and Glu152 of the core enzyme domain (6, 25) . Dinucleotides inhibited binding of the enzyme to its substrate DNA (Fig. 6 ). (Table 1) . These results suggest that dinucleotides affect the binding site of the enzyme for its DNA substrate.
Inhibition of related lentiviral integrases. The pCA dinucleotide was tested for inhibition of the related retroviral integrases from HIV-2, SIV, and FIV. As seen in Fig. 7 , when HIV-1 DNA was used in all reactions, pCA inhibited both 3Ј-processing and strand transfer catalyzed by HIV-1 integrase in the expected concentration range. The IC 50 values were 88 and 15 M for 3Ј-processing and strand transfer, respectively. Similarly, HIV-2 integrase was inhibited with IC 50 values of 125 and 10 M for 3Ј-processing and strand transfer, respectively. As in the case of HIV-1 integrase, pCA was ϳ12-fold more selective in inhibiting the strand transfer reaction than the 3Ј-processing reaction with HIV-2 integrase. Although strand transfer catalyzed by FIV integrase was inhibited in the same concentration range (IC 50 ϭ 46 M) as that for the HIV-1 and -2 integrases, 3Ј-processing catalyzed by this integrase was inhibited with an IC 50 value of ϳ1000 M. The differential inhibition of the two activities catalyzed by FIV and SIV integrases was ϳ20-40-fold. Therefore, the pCA dinucleotide appeared to inhibit HIV-1 and -2 integrases more efficiently than the FIV and SIV integrases. 
Discussion
Sequence selectivity in the inhibition of HIV-1 integrase. In the present study, several dinucleotides were found to be potent inhibitors of both 3Ј-processing and strand transfer catalyzed by HIV-1 integrase. Some sequence selectivity was evident, with pAC, pAT, and pCT being the most potent and pAA, pGA, and pGC showing weak activity at 100 M. The lack of a more unambiguous sequence selectivity was consistent with the nonspecific DNA binding capability of integrase (26) and with interactions with other parts of the dinucleotide (e.g, the phosphodiester backbone or the sugar moiety) being critical (Figs. 3 and 4) .
The sequence selectivity observed in the inhibition by dinucleotides is, however, consistent with the catalytic mechanism for 3Ј-processing. For example, before the reaction, integrase presumably binds near the scissile bond (i.e., the bond between the A and G nucleotides on the plus strand) (Fig. 1A) . The dinucleotides immediately upstream of the scissile bond are a 5Ј-CA-3Ј and 5Ј-TG-3Ј on the plus and minus strand, respectively (Fig. 1A) . Binding of integrase to these dinucleotides in the recognition sequence should therefore not inhibit the subsequent endonuclease reaction or catalysis would not occur. Accordingly, neither of these dinucleotides exhibited potency against 3Ј-processing at Ͻ100 M (Table 1) . These dinucleotides could therefore provide a binding site on the viral DNA substrate, which would allow the 3Ј-processing reaction to proceed unhindered. These results are consistent with earlier reports that mutation of the 5Ј-GCA-3Ј trinucleotide at the-processing site on the scissile strand resulted in inhibition of the 3Ј-processing reaction (21, 27, 28) , further supporting the contention that the residues immediately upstream of the dinucleotide cleavage site in the 3Ј-processing reaction may provide a critical recognition/ binding site for the integrase. The relative lack of potency observed with the 5Ј-GT-3Ј dinucleotide (Table 1) suggests that this reaction product (Fig. 1C) , which results from hydrolysis of the scissile phosphodiester bond in the 3Ј-processing reaction, may not serve to regulate this reaction.
The most potent dinucleotide that exhibited IC 50 values of Յ5 M was pAC. This finding is consistent with the observation that interactions between integrase and the ultimate and penultimate bases at the 5Ј end of the noncleaved strand (5Ј-AC-3Ј) (Fig. 1A) could be the basis for stable complex formation before the strand transfer reaction (29) . Therefore, the potent inhibitory activity of pAC is presumably a manifestation of the binding affinity that integrase may have for this dinucleotide sequence.
Effects of 5-phosphorylation and trinucleotides. 5Ј-Phosphorylation of both dinucleotides and trinucleotides enhanced potency compared with the corresponding nonphosphorylated form, which is consistent with the earlier reported effects of 5Ј-phosphorylation on mononucleosides (8) and with the nonspecific binding of integrase to and inhibition by nucleic acids (26) and polyanions (30) . Inhibition with 5Ј-phosphorylated dinucleotides was observed at 10-20-fold lower concentrations than with mononucleotides such as AZT (8) and D4T monophosphates (2). However, lengthening of the oligonucleotide further did not increase potency as significantly. These data suggest that two neighboring bases may be sufficient to provide the essential interactions when integrase recognizes its viral DNA substrate.
Interaction of HIV-1 integrase with the phosphodiester backbone. Previous reports using duplex oligonucleotide substrates containing ethylated phosphodiester (31) or methylphosphonodiester (32) backbones have shown that these substitutions dramatically lower the extent of both 3Ј-processing and strand transfer reactions. These data suggested the importance of interactions with the phosphodiester backbone. This hypothesis was probed by investigating the effect of neutralizing the negative charge in the backbone of various CA dinucleotides and examining the resulting extent of inhibition. Elimination of the anionic character of the backbone by substitution with a methylphosphonodiester backbone was sufficient to abolish potency. Therefore, the negative charge in these dinucleotides may serve to position the inhibitor for critical interactions with the divalent metal ion (29) or basic amino acids in the active site (33) so that high affinity binding can occur.
Two predictions would be consistent with this hypothesis. First, an increase in anionic character could serve to optimize interactions within the active site. This prediction is supported by the observation that inhibition with 5Ј-phosphorylated dinucleotides was observed at 10-20-fold lower concentrations than with nonphosphorylated dinucleotides. The same trend was observed with mononucleotides of AZT (8) and D4T (2) . Second, correct positioning of the 5Ј-phosphorylated dinucleotide may require proximity of the anionic charge from both the phosphodiester backbone and the 5Ј-phosphate to appropriate counter ions. This prediction is supported by the observation that the cyclic structure abolished potency relative to the linear structure. In this case, either the decrease in anionic charge from three (for the linear, phosphorylated dinucleotide) to two (for the cyclic dinucleotide) or the movement of the 5Ј-phosphate might be responsible for the lack of inhibition. The lack of inhibition by, and presumably low affinity for, the cyclic dinucleotides may also be a manifestation of the requirement for product dissociation after the 3Ј-processing reaction (if the viral DNA hydroxyl has been used as a nucleophile in this endonuclease reaction to generate a cyclic dinucleotide) and before the strand transfer reaction. The low affinity for the cyclic dinucleotides also suggests that these compounds, like their Interaction of HIV-1 integrase with the sugar moiety. Previous reports with mononucleotides have suggested that critical interactions between integrase and the sugar moeity may contribute to the binding affinity of and inhibition by these compounds (2, 33) . For example, deoxyribose modifications such as substitution of a ␤-L-enantiomer for its ␤-D-counterpart, unsaturation between the 2Ј and 3Ј carbons, or substitution by an azido or a fluoro substituent at the 3Ј position conferred inhibitory activity against HIV-1 integrase compared with the unsubstituted nucleotide (2) . Furthermore, oxidation of ATP, generating the 2Ј,3Ј-dialdehyde, resulted in a nucleotide analog that was Ͼ30-fold as potent as an integrase inhibitor than ATP (33) .
In this study, the possible effect of sugar pucker in integrase inhibition was examined by substitution of the deoxyribose (C2Ј-endo) by a ribose (C3Ј-endo) in a CA dinucleotide. Substitution of the deoxyribose enhanced potency of the nonphosphorylated CA dinucleotide to approximately the same extent as did 5Ј-phosphorylation. These data also suggest that interactions with the sugar may play as critical a role as those with the 5Ј-phosphomonoester.
Dinucleotides as pharmacological agents. In addition to being 10-100-fold more potent than their corresponding mononucleotides, 5Ј-phosphorylated dinucleotides also exhibit potency in the same range as other recently described integrase inhibitors (10, 12, 34) . Furthermore, cellular uptake of 5Ј-phosphorylated dinucleotides may not require specialized delivery vehicles. Other anionic mononucleotides and oligonucleotides have been found to cross the cell membrane and act as inhibitors of intracellular targets. For example, phosphonylmethoxypropyladenine (35) and a guanosine quartet-forming oligonucleotide (36) , both of which are currently under preclinical investigation as anti-HIV agents, have been shown to accumulate inside cells. None of the dinucleotides tested in that study, however, exhibited inhibition of HIV replication or cytotoxicity at concentrations of Յ30 M.
We investigated whether some of the most potent dinucleotides in this report had antiviral activity by using the cell protection assay against the cytopathic effects of HIV-1 LAI strain. None of the dinucleotides tested [pCA, rCA, CA, pAC, cDD, cCC, pCA(PS), and pCA(MP); see Figs. 3 and 4 for structures] had significant antiviral activity. They also exhibited no cytotoxicity by themselves at concentrations of Յ200 M. At this time, it is not clear whether this lack of activity/cytotoxicity is due to cellular uptake, stability, or both. These data suggest that additional modifications may be required to achieve antiviral effects. Along these lines, it is interesting to note that a guanosine quartet oligonucleotide with potent antiviral activity is also among the most potent known inhibitors of HIV integrases (37) . Another application of dinucleotides involves the possible use of these watersoluble inhibitors as lead compounds for further antiviral development if cocrystals could be obtained.
